ESPEN Expert Statements and Practical Guidance on Clinical Nutrition in COVID-19 Patients

Shanjun Tan,Guohao Wu
DOI: https://doi.org/10.1016/j.clnu.2020.05.026
IF: 7.643
2020-01-01
Clinical Nutrition
Abstract:We read with great interest the recent European Society for Clinical Nutrition and Metabolism (ESPEN) concise guidance on clinical nutrition in COVID-19 patients, with regard to those in the ICU setting or in the presence of 70 older age and polymorbidity [1Barazzoni R. Bischoff S.C. Breda J. Wickramasinghe K. Krznaric Z. Nitzan D. et al.ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.Clin Nutr. 2020; 39: 1631-1638Abstract Full Text Full Text PDF PubMed Scopus (559) Google Scholar]. The guidance included 10 practical recommendations, which were based on current ESPEN guidelines and further expert advice. This is a timely and excellent work and the authors should be congratulated. However, we have one but possible very important issue concerning the disease that the guidance focused on. In the present guidance, the term SARS-CoV-2 appeared several times, but its detailed information, especially the relationship with COVID-19 was not stated, and this may easily cause confusion among readers, what is SARS-CoV-2, whether COVID-19 is induced by SARS-CoV-2, or it is another new coronavirus virus. In fact, the term SARS-CoV-2 was used to name the novel coronavirus virus that induced COVID-19 pandemic in 2019, which was proposed by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses [2Gorbalenya A.E. Baker S.C. Baric R.S. de Groot R.J. Drosten C. Gulyaeva A.A. et al.The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.Nat Microbiol. 2020; 5: 536-544Crossref PubMed Scopus (5066) Google Scholar]. Therefore, to avoid the confusion above, more information about SARS-CoV-2 is necessary. We would welcome other comments as this would be helpful to better understand this practical guidance for nutritional management of COVID-19 patients. This study was sponsored by National Natural Science Foundation of China (81900484), Project funded by China Postdoctoral Science Foundation (2019M661370), Shanghai Sailing Program (18YF1404700), Municipal Natural Science Foundation of Shanghai of China (19ZR1409100), and Construction Program of Key but Weak Disciplines of Shanghai Health Commission-Clinical Nutrition (2019ZB0105). Guohao Wu designed the manuscript. Shanjun Tan drafted the manuscript. All authors critically revised the article and approved the final manuscript. The authors declare no conflicts of interest.
What problem does this paper attempt to address?